GCS CONNECT
-
Leaders S6: E09- Who Is Accountable When AI Gets It Wrong? | AI Governance, Risk & LeadershipWhen AI makes a decision… who is responsible? In this episode of the GCS Leaders Series, David Bloxham speaks with Phil Lunn, Founder & CEO of Plator Ltd, about the growing challenges of AI governance, risk, ethics, and accountability in modern business.
-
Leaders S6: E08 -Why AI Won't Replace Leaders But Will Redefine Them | Benjamin Schleis & David BloxhamAs artificial intelligence continues to transform industries, one question is becoming increasingly important: What will leadership look like in an AI-enabled future? In this episode of the GCS Leaders Series Podcast, David Bloxham, CEO of GCS, sits down with Benjamin Schleis, Defence & Technology Leader, to explore how leadership is evolving in a world shaped by AI, innovation, and accelerating technological change.
-
Leaders S6: E07 - AI, Cybersecurity & Quantum Risks: What Leaders Must Know NOWAI is changing cybersecurity faster than most organisations can keep up. In this episode of the GCS Leaders Series, David Bloxham (CEO, GCS) sits down with David Brown, Security Operations and Defense Director at CyberGate Defense, to explore the future of cybersecurity, AI-driven defence, quantum resilience, cyber hygiene, and the growing challenge of securing talent in a rapidly evolving threat landscape.
-
Leaders S6: E06 - Why 85% of Neurodivergent Talent Is Overlooked | URhired x GCS Leaders Series S6E6What if the talent you’re missing is the talent you need most? In this episode of the GCS Leaders Series Podcast (S6E6), David Bloxham (CEO, GCS) sits down with Owen Murray, Founder & CEO of URhired (Dublin) a platform transforming how neurodivergent talent is supported, hired, and empowered.
-
Leaders Series S6 EP 5: AI in Drug Discovery: Hype vs Reality | GCS Leaders Series S6 E5 with Aylin CakirogluIs AI truly transforming drug discovery or are we still in the hype phase? In this episode of the GCS Leaders Series Podcast, host David Bloxham (CEO, GCS) sits down with Aylin Cakiroglu, Independent Consultant in AI for Drug Discovery, to explore how AI is reshaping pharma and biotech. From large language models in biology to the real limitations of data, this episode dives deep into the true impact of AI in life sciences.
-
Leaders Series S6 EP 4: AI, Cloud & Digital Transformation Leadership | Interim IT Director Anne-Marie Rajandream |In this episode of the GCS Leaders Series Podcast, GCS CEO David Bloxham speaks with one of Europe’s leading Interim IT & Transformation Directors, Ann-Marie Rajandream, about AI, cloud transformation, leadership under pressure, and the future of tech careers. Anne-Marie specialises in stepping into complex organisations to deliver strategic cloud-driven change, lead digital transformation, and align technology with long-term business vision.
-
Leaders Series S6 EP 3: Mastering Leadership Transformation, AI & Executive Coaching with Colin Hiles & David BloxhamThe episode also explores how AI and automation are reshaping leadership roles, helping executives refocus on what really matters: people, decision-making, and impact. Whether you’re a CEO, senior leader, or aspiring manager, this episode delivers clear, actionable insights to help you lead with more intention and clarity.
-
Leaders Series S6 EP 2: How AI Is Revolutionizing Leadership | Barrett Abernethy & GCS CEO David BloxhamThe rules of leadership are being rewritten by AI. Are you ready to lead teams that include both humans and intelligent agents?
-
Leaders Series S6 EP 1: Why WiFi Fails & How AI Fixes It | Rob Suero (Beegol) on Broadcast Tech, Leadership & The FutureDiscover how AI is transforming broadcast tech, boosting network reliability, and reshaping careers. Rob Suero (Beegol) joins David Bloxham (GCS) to share actionable leadership and innovation insights for the future of streaming. Watch now!




















































































Leader Series